Search

Your search keyword '"Milicic, D."' showing total 416 results

Search Constraints

Start Over You searched for: Author "Milicic, D." Remove constraint Author: "Milicic, D."
416 results on '"Milicic, D."'

Search Results

4. Lower Platelet Count Following Induction with Antithymocyte Globulin is Associated with a Lower Incidence of Cardiac Allograft Vasculopathy

5. Intravenous angiotensin II as an add-on to standard of care vasopressors in patients with refractory shock on mechanical circulatory support: a single centre retrospective case series

6. Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

7. Predominance of a rare transthyretin mutation (p.Asp38Glu) in patients with hATTR cardiomyopathy: initial data from the Croatian Transthyretin Cardiac Amyloidosis Registry (CroATTR)

8. Incidence of restenosis after drug-coated balloon percutaneous coronary intervention in patients with diabetes mellitus - a single-centre experience

12. Heart failure in patients is associated with downregulation of mitochondrial quality control genes.

13. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial

14. Gender Difference in the Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry.

15. Age-Related Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry.

18. Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice:: GLORIA-AF Registry

19. The case against premature treatment of heart failure patients with implantable cardioverter-defibrillators: results from an institutional registry

20. Relation between sex and mortality after myocardial infarction in high-income and middle-income European countries

21. Prognostic value of brain natriuretic peptide in COVID-19 with or without acute heart failure

22. Prevalence of standard modifiable cardiovascular risk factors in patients with ST segment elevation myocardial infarction and its relation with outcomes

23. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Trial

24. COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction

25. COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology

26. Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology

27. Is early percutaneous coronary intervention safe in patients ACS and cancer?

30. Cardiac emergencies following earthquake

31. COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction

32. Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology

33. Impact analysis of heart failure across European countries: an ESC-HFA position paper

34. Reduced Heart Failure and Mortality in Patients Receiving Statin Therapy Before Initial Acute Coronary Syndrome

35. Hybrid Dorsal Preservation Rhinoplasty: How We Do It

37. Acute heart failure: a mechanism underscoring sex differences in outcomes following acute coronary syndromes

38. IS A FAMILY HISTORY OF CORONARY HEART DISEASE AN INDEPENDENT CARDIOVASCULAR RISK FACTOR?

40. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

41. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

42. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

43. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

45. Statins for primary prevention among elderly men and women

48. His pacing program: a 2-year single-centre experience

49. Mortality, appropriate and inappropriate shocks - observations from an institutional implantable cardioverter defibrillator registry

50. Cardioverter-related complications: observations from an institutional implantable cardioverter defibrillator registry

Catalog

Books, media, physical & digital resources